The bioavailability of dissolved
Pt(IV) and polyvinylpyrrolidone-coated
platinum nanoparticles (PtNPs) of five different nominal hydrodynamic
diameters (20, 30, 50, 75, and 95 nm) was characterized in laboratory
experiments using the model freshwater snail Lymnaea stagnalis. Dissolved Pt(IV) and all nanoparticle sizes were bioavailable to L. stagnalis. Platinum bioavailability, inferred from conditional
uptake rate constants, was greater for nanoparticulate than dissolved
forms and increased with increasing nanoparticle hydrodynamic diameter.
The effect of natural organic matter (NOM) composition on PtNP bioavailability
was evaluated using six NOM samples at two nanoparticle sizes (20
and 95 nm). NOM suppressed the bioavailability of 95 nm PtNPs in all
cases, and DOM reduced sulfur content exhibited a positive correlation
with 95 nm PtNP bioavailability. The bioavailability of 20 nm PtNPs
was only suppressed by NOM with a low reduced sulfur content. The
physiological elimination of Pt accumulated after dissolved Pt(IV)
exposure was slow and constant. In contrast, the elimination of Pt
accumulated after PtNP exposures exhibited a triphasic pattern likely
involving in vivo PtNP dissolution. This work highlights
the importance of PtNP size and interfacial interactions with NOM
on Pt bioavailability and suggests that in vivo PtNP
transformations could yield unexpectedly higher adverse effects to
organisms than dissolved exposure alone.